These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11701091)

  • 1. General Practitioners' views on the provision of nicotine replacement therapy and bupropion.
    McEwen A; West R; Owen L
    BMC Fam Pract; 2001; 2():6. PubMed ID: 11701091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General practitioners' views on and referral to NHS smoking cessation services.
    McEwen A; West R; Owen L; Raw M
    Public Health; 2005 Apr; 119(4):262-8. PubMed ID: 15733685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
    McEwen A; West R; Owen L
    Addiction; 2004 Nov; 99(11):1470-4. PubMed ID: 15500600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies.
    Vogt F; Hall S; Marteau TM
    BMC Public Health; 2006 Nov; 6():277. PubMed ID: 17092346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General practitioners' beliefs about effectiveness and intentions to recommend smoking cessation services: qualitative and quantitative studies.
    Vogt F; Hall S; Marteau TM
    BMC Fam Pract; 2007 Jul; 8():39. PubMed ID: 17615061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    Cahill K; Stevens S; Perera R; Lancaster T
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discussion of NRT and other antismoking interventions in UK general practitioners' routine consultations.
    Coleman T; Wynn A; Barrett S; Wilson A
    Nicotine Tob Res; 2003 Apr; 5(2):163-8. PubMed ID: 12745488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services.
    McEwen A; West R
    BMC Public Health; 2009 Jan; 9():28. PubMed ID: 19159473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
    Johnson M; Anderson P; Lockhart I
    BMC Fam Pract; 2014 Mar; 15():47. PubMed ID: 24645823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General Practitioners' views on the English national smoking cessation guidelines.
    McEwen A; Akotia N; West R
    Addiction; 2001 Jul; 96(7):997-1000. PubMed ID: 11440609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking cessation guidelines for health professionals: an update. Health Education Authority.
    West R; McNeill A; Raw M
    Thorax; 2000 Dec; 55(12):987-99. PubMed ID: 11083883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing of smoking cessation medication in England since the introduction of varenicline.
    Langley TE; Huang Y; McNeill A; Coleman T; Szatkowski L; Lewis S
    Addiction; 2011 Jul; 106(7):1319-24. PubMed ID: 21395894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
    Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
    Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs to support smoking cessation in UK general practice: are evidence based guidelines being followed?
    Wilson A; Sinfield P; Rodgers S; Hammersley V; Coleman T
    Qual Saf Health Care; 2006 Aug; 15(4):284-8. PubMed ID: 16885254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of The Health Improvement Network (THIN) primary care database for monitoring prescriptions for smoking cessation medications.
    Langley TE; Szatkowski L; Gibson J; Huang Y; McNeill A; Coleman T; Lewis S
    Pharmacoepidemiol Drug Saf; 2010 Jun; 19(6):586-90. PubMed ID: 20535756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.K. general practitioners' beliefs, attitudes, and reported prescribing of nicotine replacement therapy in pregnancy.
    Herbert R; Coleman T; Britton J
    Nicotine Tob Res; 2005 Aug; 7(4):541-6. PubMed ID: 16085525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.
    Kotz D; Wagena EJ; Wesseling G
    Respir Med; 2007 Mar; 101(3):568-73. PubMed ID: 16890419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.